Small compound bigelovin exerts inhibitory effects and triggers proteolysis of E2F1 in multiple myeloma cells

No abstract is available for this paper.

• Publication year

  2013

• Venue

  Cancer Science

• Publication date

  2013-12-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1111/cas.12295PMID 24118350PMCID PMC7654247
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Control of autophagic cell death by caspase-10 in multiple myeloma.

  2013cited by this paper
• Small compound bigelovin exerts inhibitory effects and triggers proteolysis of E2F1 in multiple myeloma cells

  2013cited by this paper
• Largazole Arrests Cell Cycle at G1 Phase and Triggers Proteasomal Degradation of E2F1 in Lung Cancer Cells.

  2013cited by this paper
• Caspase functions in cell death and disease.

  2013cited by this paper
• MEROPS: the database of proteolytic enzymes, their substrates and inhibitors

  2013cited by this paper
• The dark side of E2F1: in transit beyond apoptosis.

  2012cited by this paper
• Re: Expression Signature of E2F1 and its Associated Genes Predict Superficial to Invasive Progression of Bladder Tumors.

  2011cited by this paper
• Structure basis of bigelovin as a selective RXR agonist with a distinct binding mode.

  2011cited by this paper
• MEROPS: the database of proteolytic enzymes, their substrates and inhibitors

  2011cited by this paper
• Translating DNA damage into cancer cell death-A roadmap for E2F1 apoptotic signalling and opportunities for new drug combinations to overcome chemoresistance.

  2010cited by this paper
• Expression signature of E2F1 and its associated genes predict superficial to invasive progression of bladder tumors.

  2010cited by this paper
• Small Compound 6-O-Angeloylplenolin Induces Mitotic Arrest and Exhibits Therapeutic Potentials in Multiple Myeloma

  2010cited by this paper
• APC/CCdc20 targets E2F1 for degradation in prometaphase

  2010cited by this paper
• hyperphosphory-E2F1 in Melanoma Progression and Metastasis

  2010cited by this paper
• E2F1 in melanoma progression and metastasis.

  2010cited by this paper
• E2F1 expression is deregulated and plays an oncogenic role in sporadic Burkitt's lymphoma.

  2009cited by this paper
• E2F1-3 Switch from Activators in Progenitor Cells to Repressors in Differentiating Cells

  2009cited by this paper
• Division and apoptosis of E2f-deficient retinal progenitors

  2009cited by this paper
• Gene expression of anti‐ and pro‐apoptotic proteins in malignant and normal plasma cells

  2009cited by this paper
• Nuclear factor kappaB-mediated down-regulation of adhesion molecules: possible mechanism for inhibitory activity of bigelovin against inflammatory monocytes adhesion to endothelial cells.

  2009cited by this paper
• Apoptosis inducement of bigelovin from Inula helianthus‐aquatica on human Leukemia U937 cells

  2009cited by this paper
• Emerging roles of E2Fs in cancer: an exit from cell cycle control

  2009cited by this paper
• Mutational analysis of CASP10 gene in acute leukaemias and multiple myelomas

  2009cited by this paper
• E2F1 inhibits c-Myc-driven apoptosis via PIK3CA/Akt/mTOR and COX-2 in a mouse model of human liver cancer.

  2008cited by this paper
• An E2F1-dependent gene expression program that determines the balance between proliferation and cell death.

  2008cited by this paper
• Caspase polymorphisms and genetic susceptibility to multiple myeloma

  2008cited by this paper
• Prognostic and biological implications of genetic abnormalities in multiple myeloma undergoing autologous stem cell transplantation: t(4;14) is the most relevant adverse prognostic factor, whereas RB deletion as a unique abnormality is not associated with adverse prognosis

  2007cited by this paper
• E2F1 Overexpression Correlates with Thymidylate Synthase and Survivin Gene Expressions and Tumor Proliferation in Non–Small-Cell Lung Cancer

  2007cited by this paper
• Sesquiterpene lactones from Inula britannica and their cytotoxic and apoptotic effects on human cancer cell lines.

  2006cited by this paper
• AML1-ETO and C-KIT mutation/overexpression in t(8;21) leukemia: implication in stepwise leukemogenesis and response to Gleevec.

  2005cited by this paper
• FTY720 induces apoptosis in multiple myeloma cells and overcomes drug resistance.

  2005cited by this paper
• International staging system for multiple myeloma.

  2005cited by this paper
• G1 cell-cycle control and cancer

  2004cited by this paper
• Overexpression of E2F-1 in Lung and Liver Metastases of Human Colon Cancer is Associated with Gene Amplification

  2004cited by this paper
• Inactivating E2f1 reverts apoptosis resistance and cancer sensitivity in Trp53-deficient mice

  2003cited by this paper
• Evidence for distinct pathomechanisms in B-cell chronic lymphocytic leukemia and mantle cell lymphoma by quantitative expression analysis of cell cycle and apoptosis-associated genes.

  2002cited by this paper
• E2Fs regulate the expression of genes involved in differentiation, development, proliferation, and apoptosis.

  2001cited by this paper
• Cyclin D1 and E2F‐1 immunoreactivity in bone marrow biopsy specimens of multiple myeloma: relationship to proliferative activity, cytogenetic abnormalities and DNA ploidy

  2001cited by this paper
• Cell cycle-mediated drug resistance: an emerging concept in cancer therapy.

  2001cited by this paper
• Immunohistochemical expression of the p53, p21/Waf-1, Rb, p16 and Ki67 proteins in multiple myeloma.

  2000cited by this paper
• Expression of the E2F family in human gastrointestinal carcinomas

  1999cited by this paper
• Expression of the cell-cycle-related proteins E2F-1, p53, mdm-2, p21waf-1, and Ki-67 in multiple myeloma: correlation with cyclin-D1 immunoreactivity.

  1998cited by this paper
• Cytotoxic Sesquiterpene Lactones from Inula britannica

  1998cited by this paper
• Regulation of E2F through ubiquitin-proteasome-dependent degradation: stabilization by the pRB tumor suppressor protein.

  1997cited by this paper
• E2F-1 Degradation by the Ubiquitin-Proteasome Pathway

  1997cited by this paper
• Degradation of E2F by the ubiquitin-proteasome pathway: regulation by retinoblastoma family proteins and adenovirus transforming proteins.

  1996cited by this paper
• The retinoblastoma gene product protects E2F-1 from degradation by the ubiquitin-proteasome pathway.

  1996cited by this paper
• Anti-emetic principles of Inula linariaefolia flowers and Forsythia suspensa fruits.

  1996cited by this paper
• The transcription factor E2F is required for S phase during Drosophila embryogenesis.

  1995cited by this paper
• The Sesquiterpenoid Lactones of Helenium Bigelovii Gray

  1962cited by this paper

• Disruption of cellular redox homeostasis by bigelovin triggers oxidative stress-mediated apoptosis in Fibrosarcoma.

  2025cites this paper
• Bigelovin inhibits hepatocellular carcinoma cell growth and metastasis by regulating the MAPT-mediated Fas/FasL pathway.

  2023cites this paper
• Identification of evolutionary mechanisms of myelomatous effusion by single-cell RNA sequencing

  2022influential citation
• Sesquiterpene lactone Bigelovin induces apoptosis of colon cancer cells through inducing IKK-β degradation and suppressing nuclear factor kappa B activation

  2021cites this paper
• Cytotoxic constituents and a new hydroxycinnamic acid derivative from Leontodon saxatilis (Asteraceae, Cichorieae)

  2021cites this paper
• Multiple Myeloma Inhibitory Activity of Plant Natural Products

  2021cites this paper
• Key Genes And Pathways Controlled By E2F1 In Human Castration-Resistant Prostate Cancer Cells

  2019cites this paper
• Key Genes And Pathways Controlled By E2F1 In Human Castration-Resistant Prostate Cancer Cells

  2019cites this paper
• Key Genes And Pathways Controlled By E2F1 In Human Castration-Resistant Prostate Cancer Cells

  2019cites this paper
• In silico experiment system for testing hypothesis on gene functions using three condition specific biological networks.

  2018cites this paper
• Celastrol downregulates E2F1 to induce growth inhibitory effects in hepatocellular carcinoma HepG2 cells.

  2017cites this paper
• Bigelovin triggered apoptosis in colorectal cancer in vitro and in vivo via upregulating death receptor 5 and reactive oxidative species

  2017cites this paper
• Bigelovin inhibits STAT3 signaling by inactivating JAK2 and induces apoptosis in human cancer cells

  2015cites this paper
• Small compound bigelovin exerts inhibitory effects and triggers proteolysis of E2F1 in multiple myeloma cells

  2013cites this paper
• Celastrol downregulates E 2 F 1 to induce growth inhibitory effects in hepatocellular carcinoma HepG 2 cells

  year unknowncites this paper